Show Summary Details
Page of

Wilson’s Disease 

Wilson’s Disease
Wilson’s Disease

Roger M. Kurlan

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 April 2021

Wilson’s disease (WD) is an autosomal recessive disorder of copper metabolism that is caused by a mutation in the gene ATP7B. Patients with WD can present with a hyperkinetic movement disorder usually consisting of dystonia and tremor. Chorea may also occur. Other neurological manifestations can include parkinsonism, cerebellar signs, pseudobulbar features, drooling, and seizures. Dementia and psychiatric features are also potential presenting or associated features. Patients may present with a variety of different systemic disturbances most commonly involving the liver, kidneys, bone marrow, skeleton and eyes. The illness is curable with appropriate therapy that typically includes a low-copper diet and the use of decoppering medications. Careful long-term clinical and laboratory monitoring is needed to ensure effective therapy. Relatives of affected individuals should be tested and treated if they have WD in order to prevent clinical expression.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.